Related Experiment Videos
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue
M Kjalke1, D M Monroe, M Hoffman
1Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, USA. mkja@novo.dk
Abstract:
Factors VIIa, Xa, and IXa play different roles in the initiation of tissue factor-dependent coagulation. The consequences of competing with the different enzymes were investigated, thereby examining the effects of inhibiting the initiation process at different steps. Active site-inactivated factors VIIa, Xa, and IXa (FVIIai, FXai, and FIXai, respectively) were added to various cell-based assays mimicking the individual steps in tissue factor-initiated coagulation. In an assay involving tissue factor-expressing monocytes, coagulation proteins and unactivated platelets, FVIIai and FXai inhibited platelet activation and thrombin generation while FIXai only inhibited thrombin generation. FVIIai inhibited factor Xa generation and subsequent thrombin generation on monocytes, while FXai inhibited thrombin generation on the monocytes as well as on the activated platelets. FIXai had no effect on factor Xa or thrombin generation on the monocytes, but inhibited factor Xa and subsequent thrombin generation on the activated platelets. FVIIai had no effect on the reactions taking place on the activated platelets. The data confirm a model where tissue factor/factor VIIa mediates factor Xa generation and subsequent prothrombin activation on the tissue factor-bearing cells. Thrombin then activates platelets, which serve as the physiologically important surface for large-scale thrombin generation.
Insights
Inhibiting specific coagulation factors (VIIa, Xa, IXa) reveals distinct roles in blood clotting initiation. Factor VIIa and Xa block platelet activation and thrombin generation, while IXa only affects thrombin generation.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Coagulation factors VIIa, Xa, and IXa are crucial for initiating the tissue factor-dependent coagulation cascade.
- Understanding the distinct roles of these factors is essential for developing targeted anticoagulant therapies.
Purpose of the Study:
- To investigate the specific contributions of factors VIIa, Xa, and IXa to coagulation initiation.
- To examine the effects of inhibiting these factors at different stages of the tissue factor pathway.
Main Methods:
- Utilized cell-based assays mimicking steps in tissue factor-initiated coagulation.
- Employed active site-inactivated factors VIIa, Xa, and IXa (FVIIai, FXai, FIXai) as inhibitors.
- Assayed inhibition of platelet activation and thrombin generation in the presence of tissue factor-expressing monocytes, coagulation proteins, and platelets.
Main Results:
- FVIIai and FXai inhibited both platelet activation and thrombin generation.
- FIXai selectively inhibited thrombin generation.
- FVIIai blocked factor Xa generation and subsequent thrombin generation on monocytes; FXai inhibited thrombin generation on monocytes and activated platelets.
- FIXai demonstrated inhibitory effects on activated platelets but not on monocytes.
Conclusions:
- Tissue factor/factor VIIa drives factor Xa generation and prothrombin activation on tissue factor-bearing cells.
- Thrombin subsequently activates platelets, creating a surface for amplified thrombin generation.
- The study confirms a sequential model of coagulation initiation and highlights distinct inhibitory profiles of FVIIai, FXai, and FIXai.